Carol Cass

Author PubWeight™ 11.37^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Gastric adenocarcinoma: review and considerations for future directions.	Ann Surg	2005	3.83
2	The absence of human equilibrative nucleoside transporter 1 is associated with reduced survival in patients with gemcitabine-treated pancreas adenocarcinoma.	Clin Cancer Res	2004	2.06
3	Lymphovascular invasion is associated with poor survival in gastric cancer: an application of gene-expression and tissue array techniques.	Ann Surg	2006	1.20
4	cN-II expression predicts survival in patients receiving gemcitabine for advanced non-small cell lung cancer.	Lung Cancer	2005	1.09
5	Prognostic role of human equilibrative transporter 1 (hENT1) in patients with resected gastric cancer.	J Cell Physiol	2010	1.02
6	Nitric oxide and cyclic GMP increase the expression of matrix metalloproteinase-9 in vascular smooth muscle.	J Pharmacol Exp Ther	2003	0.90
7	Clinically validated benchmarking of normalisation techniques for two-colour oligonucleotide spotted microarray slides.	Appl Bioinformatics	2003	0.83
8	Synthesis, transportability and hypoxiaselective binding of 1-beta-D-(5-Deoxy-5-fluororibofuranosyl)-2-nitroimidazole (beta-5-FAZR), a configurational isomer of the clinical hypoxia marker, FAZA.	J Pharm Pharm Sci	2007	0.80